Viemed Healthcare Stock Alpha and Beta Analysis
| VMD Stock | USD 7.57 0.14 1.82% |
This module allows you to check different measures of market premium (i.e., alpha and beta) for all equities such as Viemed Healthcare. It also helps investors analyze the systematic and unsystematic risks associated with investing in Viemed Healthcare over a specified time horizon. Remember, high Viemed Healthcare's alpha is almost always a sign of good performance; however, a high beta will depend on investors' risk tolerance level and may signal increased volatility and potential future overvaluation. Key technical indicators related to Viemed Healthcare's market risk premium analysis include:
Beta 0.6 | Alpha (0.07) | Risk 1.81 | Sharpe Ratio (0.10) | Expected Return (0.18) |
Enterprise Value |
|
Alpha is a measure of relative performance on a risk-adjusted basis, while beta measures volatility against the benchmark. The goal is to know if an investor is being compensated for the volatility risk taken. The return on investment might be better than its reference but still not compensate for the assumption of the risk.
Viemed |
Viemed Healthcare Market Premiums
Investors always prefer to have the highest possible return on investment, coupled with the lowest possible volatility. Viemed Healthcare market risk premium is the additional return an investor will receive from holding Viemed Healthcare long position in a well-diversified portfolio. The market premium is part of the Capital Asset Pricing Model (CAPM), which most analysts and investors use to calculate the acceptable rate of return on investment in Viemed Healthcare. At the center of the CAPM is the concept of risk and reward, which is usually communicated by investors using alpha and beta measures. Alpha and beta are two of the key measurements used to evaluate Viemed Healthcare's performance over market.| α | -0.07 | β | 0.60 |
Viemed Healthcare expected buy-and-hold returns
Although buy-and-hold investment strategy may not appeal to all investors, it may be used as a good measure of Viemed Healthcare's Buy-and-hold return. Our buy-and-hold chart shows how Viemed Healthcare performed over your current time horizon against a typical interest-earning bank account and a selected benchmark.Viemed Healthcare Market Price Analysis
Market price analysis indicators help investors to evaluate how Viemed Healthcare stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing, and determine when trading Viemed Healthcare shares will generate the highest return on investment. By understating and applying Viemed Healthcare stock market price indicators, traders can identify Viemed Healthcare position entry and exit signals to maximize returns.
Viemed Healthcare Return and Market Media
The median price of Viemed Healthcare for the period between Sat, Dec 14, 2024 and Fri, Mar 14, 2025 is 8.02 with a coefficient of variation of 4.14. The daily time series for the period is distributed with a sample standard deviation of 0.33, arithmetic mean of 8.08, and mean deviation of 0.26. The Stock received substential amount of media coverage during this period. Price Growth (%) |
| Timeline |
1 | Disposition of 1927 shares by Trae Fitzgerald of Viemed Healthcare at 7.62 subject to Rule 16b-3 | 01/02/2025 |
2 | Disposition of 10719 shares by Heltz Sabrina of Viemed Healthcare subject to Rule 16b-3 | 01/15/2025 |
3 | Acquisition by Moore Michael of 9488 shares of Viemed Healthcare subject to Rule 16b-3 | 01/17/2025 |
4 | Acquisition by Cambre Jerome of 8789 shares of Viemed Healthcare subject to Rule 16b-3 | 01/21/2025 |
5 | Acquisition by William Zehnder of 25661 shares of Viemed Healthcare subject to Rule 16b-3 | 01/22/2025 |
6 | Acquisition by Moore Michael of 18979 shares of Viemed Healthcare subject to Rule 16b-3 | 01/23/2025 |
7 | VMD CORP TO DELIVER PASSENGER AND BAGGAGE SCREENING SERVICES AT ORLANDO SANFORD INTERNATIONAL AIRPORT | 01/29/2025 |
8 | Acquisition by Cambre Jerome of 8619 shares of Viemed Healthcare subject to Rule 16b-3 | 01/31/2025 |
9 | Acquisition by Casey Hoyt of 40068 shares of Viemed Healthcare subject to Rule 16b-3 | 02/07/2025 |
10 | Acquisition by William Zehnder of 269 shares of Viemed Healthcare subject to Rule 16b-3 | 02/14/2025 |
11 | 259,784 Shares in Viemed Healthcare, Inc. Purchased by Rice Hall James Associates LLC | 02/19/2025 |
12 | Viemed Healthcare Projected to Post Quarterly Earnings on Tuesday | 02/25/2025 |
13 | Disposition of 1742 shares by Jeremy Trahan of Viemed Healthcare at 8.15 subject to Rule 16b-3 | 02/28/2025 |
14 | Acquisition by Cambre Jerome of 3003 shares of Viemed Healthcare subject to Rule 16b-3 | 03/04/2025 |
15 | Viemed Healthcare Projected to Post Quarterly Earnings on Monday - Defense World | 03/07/2025 |
16 | Viemed Healthcare beats top-line estimates initiates FY25 outlook | 03/11/2025 |
17 | Acquisition by Casey Hoyt of 13266 shares of Viemed Healthcare subject to Rule 16b-3 | 03/13/2025 |
About Viemed Healthcare Beta and Alpha
For many years both, Alpha and Beta indicators are used by professional money managers as critical performance measurement tools across virtually all financial instruments including Viemed or other stocks. Alpha measures the amount that position in Viemed Healthcare has returned in comparison to a selected market index or another relevant benchmark. In other words, Alpha is the excess return on an investment relative to the performance of your selected benchmark. Beta, on the other hand, measures the relative risk of your investment.
| 2024 | 2025 (projected) | Dividend Yield | 0.11 | 0.1 | Price To Sales Ratio | 1.39 | 1.48 |
Viemed Healthcare Upcoming Company Events
As portrayed in its financial statements, the presentation of Viemed Healthcare's financial position is often influenced by management's estimates, judgments, and sometimes even manipulations. In the best case, Viemed Healthcare's leadership is honest, while the outside auditors are strict and uncompromising. Whatever the case, investors should always follow all of Viemed Healthcare's public filing events to personally review all filings and be reasonable and skeptical to interpret all of the financial statements of Viemed Healthcare. Please utilize our Beneish M Score to check the likelihood of Viemed Healthcare's management manipulating its earnings.
| 7th of March 2024 Upcoming Quarterly Report | View | |
| 31st of December 2023 Next Fiscal Quarter End | View |
Build Portfolio with Viemed Healthcare
Your optimized portfolios are the building block of your wealth. We provide an intuitive interface to determine which securities in a portfolio should be removed or rebalanced to achieve better diversification, find the right mix of securities that minimizes portfolio risk for a given return, or maximize portfolio expected return for a given risk level.Build Diversified Portfolios
Align your risk with return expectations
Check out Viemed Healthcare Backtesting, Viemed Healthcare Valuation, Viemed Healthcare Correlation, Viemed Healthcare Hype Analysis, Viemed Healthcare Volatility, Viemed Healthcare History and analyze Viemed Healthcare Performance. For information on how to trade Viemed Stock refer to our How to Trade Viemed Stock guide.You can also try the Content Syndication module to quickly integrate customizable finance content to your own investment portal.
Viemed Healthcare technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.